Log in or Sign up for Free to view tailored content for your specialty!
Vaccination
FDA clears Qiagen panel for meningitis, encephalitis
The FDA on Monday cleared Qiagen’s 1-hour PCR test for meningitis and encephalitis, which the company said could help treat meningococcal disease more quickly.
Q&A: App ‘much better’ than physicians at diagnosing ear infections
More than half of children with acute otitis media and 32% of children with upper respiratory infections tested positive for multiple pathogens in their nasal passages, according to a study presented at IDWeek.
Log in or Sign up for Free to view tailored content for your specialty!
COVID-19 vaccination rates plummet among nursing home personnel
There was a “marked decrease” in COVID-19 vaccine uptake among nursing home personnel last season, according to researchers, who attributed the decline to cost and the end of the CMS’s COVID-19 vaccine requirement in mid-2023.
Study raises questions about need for mpox booster doses
LOS ANGELES — Neutralizing antibodies against mpox generated by the Jynneos vaccine were short lived — lasting less than a year — if patients had never received a smallpox vaccine as children, researchers said.
ACIP votes to simplify meningococcal B vaccine recommendations
A CDC advisory committee on Thursday voted unanimously to “harmonize” serogroup B meningococcal vaccine recommendations for healthy adolescents and young adults and children who have a higher risk for infection.
Simultaneous adjuvant flu, RZV vaccines a safe, ‘acceptable option’ for older adults
The simultaneous administration of adjuvant zoster and influenza vaccines posed no additional safety risks in older adults, results from a randomized study showed.
The Story of the Flu Vaccine (Re-Release)
It's that time of year again, everyone rolling up their sleeves to get a flu shot. This throwback episode dives into the history of the struggles pinning down the causative agent of flu and the journey to the vaccine!
CDC recommends 2nd COVID shot for some, lowering age for pneumococcal vaccination
A CDC advisory committee on Wednesday recommended that adults aged 65 years or older and anyone who is at least moderately immunocompromised receive a second dose of COVID-19 vaccine this season.
Merck’s RSV shot for infants shows promise, could be available in 2025
Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.
New data pave way for wider use of mpox vaccine in adolescents, researchers say
LOS ANGELES — Interim data from a phase 2 clinical trial of the Jynneos mpox vaccine showed that it is safe and generates an antibody response in adolescents that is similar to the response seen in adults, researchers reported.
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read
-
Headline News
Q&A: ‘We have to be worried’ about decline in measles vaccination
November 19, 20244 min read -
Headline News
Physicians encouraged to ‘embrace’ technology in practice management
November 19, 20245 min read -
Headline News
Artificial neural network has ‘excellent’ performance in predicting COPD exacerbations
November 20, 20242 min read